for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Carlyle-backed Atotech aims for raise up to $751 mln in U.S. IPO

Jan 25 (Reuters) - Specialty chemicals group Atotech Ltd, backed by buyout firm Carlyle Group Inc, is looking to raise up to $751.2 million in its U.S. initial public offering, a filing with the U.S. Securities and Exchange Commission showed. (bit.ly/3sReEMG)

The Germany-based firm, which makes specialty chemicals and equipment for printed circuit boards and semiconductors, is keen on selling about 34.1 million shares at a range of between $19 and $22 apiece. About 4.9 million of these shares are being sold by the selling stockholders.

At the top end of the range, the company would be valued around $4 billion.

Reuters reported in January last year that Carlyle had decided to delay the chemical maker's IPO fearing that uncertainty around the coronavirus outbreak could hurt the company's prospective valuation. (reut.rs/3c8AF3v)

Carlyle acquired Atotech in 2016 in a deal worth $3.2 billion, including debt.

Citigroup, Credit Suisse, BofA Securities and JP Morgan are the lead underwriters for the offering.

Reporting by Niket Nishant in Bengaluru, Editing by Sherry Jacob-Phillips

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up